Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

February 09, 2016 8:07 PM ET


Company Overview of Pervasis Therapeutics, Inc.

Company Overview

Pervasis Therapeutics, Inc. engages in the development and commercialization of endothelial cell-based therapies to regulate the body’s natural healing and repair processes in various critical therapeutic areas. The company focuses on developing therapies to improve the outcomes of common vascular interventions, such as arteriovenous access, angioplasties, stent placements, and peripheral and coronary bypass grafts. Pervasis Therapeutics, Inc. also engages in developing an oncology therapy focused on preventing solid tumor growth, cancer recurrence, and metastatic disease; and products for inflammatory disease and orthopedic injury. The company's products include Vascugel, a therapeutic for ...

One Kendall Square

Suite B6101

Cambridge, MA 02139

United States

Founded in 2003

Key Executives for Pervasis Therapeutics, Inc.

Co-Founder and Director
Age: 67
Co-Founder and Advisor
Age: 66
Business Consultant
Compensation as of Fiscal Year 2015.

Similar Private Companies By Industry

Company Name Region
Pel-Freez Arkansas, LLC United States
Pinpoint Genomics, Inc. United States
Exicure Inc. United States
DecImmune Therapeutics, Inc. United States
CLINIQA Corporation United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Pervasis Therapeutics, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at